Li, Philip Kam-Tao and Bavanandan, Sunita and Mohamed, Rosmawati and Szeto, Cheuk-Chun and Wong, Vincent Wai-Sun and Chow, Kai-Ming and Dan, Yock-Young and Huang, Chiu-Ching and Lai, Ching-Lung and Tanwandee, Tawesak and Teo, Boon Wee and Wong, Grace Lai-Hung and Yeoh, Eng-Kiong and Iseki, Kunitoshi and Leung, Chi-Bon and Park, Hyeong Cheon and Kanjanabuch, Talerngsak and Lu, Wanhong and Fung, James and Jia, Jidong and Kanda, Eiichiro and Law, Man-Ching and Liu, Hong and Loo, Ching-Kong and Mak, Siu-Ka and Lui, Sing-Leung and Tang, Hon-Lok and Wang, Angela Yee-Moon and Yu, Ming-Lung and Cheung, Michael and Jadoul, Michel (2020) 2018 kidney disease: Improving global outcomes (KDIGO) Hepatitis C in chronic kidney disease guideline implementation: Asia Summit Conference report. Kidney International Reports, 5 (8). pp. 1129-1138. ISSN 2468-0249, DOI https://doi.org/10.1016/j.ekir.2020.05.001.
Full text not available from this repository.Abstract
In 2018, Kidney Disease: Improving Global Outcomes (KDIGO) published a clinical practice guideline on the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection in chronic kidney disease (CKD). The guideline synthesized recent advances, especially in HCV therapeutics and diagnostics, and provided clinical recommendations and suggestions to aid healthcare providers and improve care for CKD patients with HCV. To gain insight into the extent that the 2018 guideline has been adopted in Asia, KDIGO convened an HCV Implementation Summit in Hong Kong. Participants included nephrologists, hepatologists, and nurse consultants from 8 Southeast Asian countries or regions with comparable high-to-middle economic ranking by the World Bank: mainland China, Hong Kong, Japan, Malaysia, Singapore, South Korea, Taiwan, and Thailand. Through presentations and discussions, meeting participants described regional practice patterns related to the KDIGO HCV in CKD guideline, identified barriers to implementing the guideline, and developed strategies for overcoming the barriers in Asia and around the world.
| Item Type: | Article |
|---|---|
| Funders: | KDIGO, Fresenius Medical Care, Merck & Company |
| Uncontrolled Keywords: | Chronic kidney disease; Dialysis; Direct-acting antiviral; Infection control; Kidney transplantation |
| Subjects: | R Medicine > R Medicine (General) |
| Divisions: | Faculty of Medicine > Medicine Department |
| Depositing User: | Ms Zaharah Ramly |
| Date Deposited: | 10 Feb 2023 03:58 |
| Last Modified: | 10 Feb 2023 03:58 |
| URI: | http://eprints.um.edu.my/id/eprint/37519 |
Actions (login required)
 |
View Item |
